Neuropathic Pain Market Outlook: Growth, Share, Value, Trends, and Analysis

Neuropathic Pain Market Size And Forecast by 2031

Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031.. Neuropathic Pain Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of Size, Share, Scope, Demand, Growth, Value, Opportunities, Industry Statistics, Industry Trends, Industry Share, Revenue Analysis, Revenue Forecast, Future Scope, Challenges, Growth Drivers, leaders, graph, insights, Research Report, companies, overview, outlook and factors that are playing a substantial role in the market.

Global Neuropathic Pain Market Segmentation Analysis

Global Neuropathic Pain Market, By Type (Spinal Cord Stimulation (SCS) Devices, External Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Focal Neuropathy, Automatic Neuropathy, and Proximal Neuropathy), Product Type (Rechargeable and Non-Rechargeable), Procedure (Invasive and Non-Invasive), Technology (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Stimulation), Modality (Stationary and Portable), Mode of Purchase (Over-the-Counter Devices and Prescription-Based Devices), Pain Type (Peripheral Neuropathy, Entrapment Neuropathy, Phantom Limb Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, Foot Pain, and Coccydynia), Indication (Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, and Others), Diagnosis (Imaging, Blood Tests, and Physical Examination) Treatment ( Medications, and Multimodal Therapy) End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Research Organization, and Others), Distribution Channel (Direct Tender, Third Party Distributor and Others) – Industry Trends and Forecast to 2031.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-neuropathic-pain-market

Which are the top companies operating in the Neuropathic Pain Market?

The “Global Neuropathic Pain Market ”study report will provide a valuable insight with an emphasis on the global market. The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the Neuropathic Pain Market extension. This Neuropathic Pain Market report provides the information of the Top 10 Companies in Neuropathic Pain Market in the market their business strategy, financial situation etc.

**Segments:**

- By Drug Class: Tricyclic Antidepressants, Anticonvulsants, Serotonin-Norepinephrine Inhibitors, Opioid Painkillers, Topical Products, Others
- By Indication: Diabetic Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Postherpetic Neuralgia, Trigeminal Neuralgia, Others
- By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The global neuropathic pain market is expected to witness significant growth from 2021 to 2029. Factors such as the increasing prevalence of chronic pain conditions, growing geriatric population, and advancements in the healthcare sector are driving market growth. The market is segmented by drug class into tricyclic antidepressants, anticonvulsants, serotonin-norepinephrine inhibitors, opioid painkillers, topical products, and others. Among these, the anticonvulsants segment is anticipated to lead the market during the forecast period due to their efficacy in managing neuropathic pain. On the basis of indication, the market is categorized into diabetic neuropathy, chemotherapy-induced peripheral neuropathy, postherpetic neuralgia, trigeminal neuralgia, and others. The diabetic neuropathy segment is estimated to dominate the market owing to the rising incidence of diabetes worldwide. Furthermore, based on the distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is projected to hold a significant market share due to the availability of a wide range of neuropathic pain management drugs in these facilities.

**Market Players:**

- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- GlaxoSmithKline plc
- Eli Lilly and Company
- AstraZeneca
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Abbott
- Biogen
- Sanofi

Key market players in the globalThe global neuropathic pain market is highly competitive with several key players striving to maintain their market positions through various strategies such as mergers and acquisitions, new product launches, partnerships, and collaborations. Pfizer Inc. is one of the leading players in the market, known for its strong portfolio of neuropathic pain management drugs. The company focuses on research and development to introduce innovative treatments for neuropathic pain. Johnson & Johnson Services, Inc. is another prominent player in the market, offering a wide range of pharmaceutical products for pain management, including neuropathic pain. The company's strong distribution network and focus on expanding its product portfolio contribute to its market presence.

GlaxoSmithKline plc is also a key player in the global neuropathic pain market, with a diverse range of products for pain management, including medications for neuropathic pain. The company emphasizes strategic collaborations and partnerships to enhance its product offerings and reach a wider customer base. Eli Lilly and Company is known for its advanced research in pain management and continues to invest in developing novel therapies for neuropathic pain. AstraZeneca is another significant player in the market, focusing on bringing innovative solutions for neuropathic pain treatment. The company's widespread presence and strong marketing strategies help it maintain a competitive edge in the market.

Novartis AG is actively involved in the neuropathic pain market, with a focus on developing cutting-edge treatments for various pain conditions, including neuropathic pain. Teva Pharmaceutical Industries Ltd. is a notable player in the market, offering a range of medications for neuropathic pain management. The company's emphasis on quality and affordability makes its products accessible to a wide range of patients. Abbott is also a key player in the market, known for its commitment to developing effective therapies for neuropathic pain. Biogen focuses on research and development to introduce innovative treatments for neuropathic pain, leveraging its expertise in neuroscience.

Sanofi is a significant player in the global neuropathic pain**Market Players:**

NEVRO CORP. (U.S.)
Lilly (U.S.)
Astellas Pharma Inc. (Japan)
Biogen (U.S.)
Cirtec (U.S.)
Integer Holdings Corporation (U.S.)
B. Braun SE(Germany)
Medtronic (Ireland)
Abbott (U.S.)
Boston Scientific Corporation (U.S.)
OMRON Healthcare Co., Ltd. (Japan)
electroCore, Inc. (U.S.)
Polar Medical Ltd (U.K.)
SunMED Medical(U.S.)
NeuroMetrix, Inc. (U.S.)

The global neuropathic pain market is witnessing significant growth fueled by factors such as the rising prevalence of chronic pain conditions, the increasing geriatric population, and advancements in the healthcare sector. The market segmentation based on drug class, indication, and distribution channel provides a comprehensive overview of the industry landscape. Anticonvulsants are anticipated to lead the market among drug classes due to their efficacy in managing neuropathic pain. Diabetic neuropathy is expected to dominate the market based on indications, attributed to the growing incidence of diabetes globally. Hospital pharmacies are projected to hold a substantial market share owing to the availability of a wide range of neuropathic pain management drugs in these facilities.

In the highly competitive global neuropathic pain market, key players such as Pfizer Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Eli Lilly and Company, and Astra

Explore Further Details about This Research Neuropathic Pain Market Report https://www.databridgemarketresearch.com/reports/global-neuropathic-pain-market

Overview of the Neuropathic Pain Market Research Report

The Neuropathic Pain Market research report commences with an in-depth overview covering definitions, applications, product/service launches, developments, challenges, and regional analysis. The forecast underlines robust growth fueled by increasing consumption in diverse markets. Furthermore, the report delves into current market trends and key characteristics.

Objectives of the Report

Conduct a comprehensive investigation to forecast the value and volume of the Neuropathic Pain Market.

Analyze and project market shares for major segments within the Neuropathic Pain Market.

Depict the evolving landscape of the Neuropathic Pain Market across global regions.

Examine and assess micro markets, their contributions, and growth potential within the Neuropathic Pain Market.

Provide accurate insights into the factors driving the growth of the Neuropathic Pain Market.

Offer a detailed analysis of key strategies adopted by major companies, such as R&D, collaborations, agreements, partnerships, acquisitions, mergers, new product launches, and other strategic initiatives.

Market Overview

The study concentrates on the present state of the Neuropathic Pain Market, evaluating key statistics including CAGR, gross margin, revenue, pricing, production growth rate, volume, value, market share, and year-over-year growth. This thorough analysis is conducted using the latest primary and secondary research methods. Leading company profiles are scrutinized based on factors like the markets they serve, production, revenues, market shares, recent developments, and gross profit margins. The report also provides a detailed exploration of market drivers, constraints, opportunities, challenges, and trends within the market dynamics section.

Table of Contents:
Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
Market Purview
Report DescriptionMarket Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Application
Market Snapshot, By Region
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
And more...

Browse More Reports:

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting firm known for its innovative and unique approach, coupled with unparalleled resilience and integrated methods. We are committed to identifying prime market opportunities and delivering insightful information to help your business excel in the marketplace. Data Bridge provides customized solutions to complex business challenges, ensuring a seamless decision-making process. Founded in Pune in 2015, Data Bridge is the result of profound wisdom and extensive experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 975

Email:- corporatesales@databridgemarketresearch.com

Search This Blog

DBMRNEWS456